S'abonner

Chronic villitis as a distinctive feature of placental injury in maternal SARS-CoV-2 infection - 25/04/24

Doi : 10.1016/j.ajog.2024.04.002 
Lauryn C. Gabby, MD a, Chelsea K. Jones, MD b, Brendan B. McIntyre, MD b, Zoe Manalo, BS c, d, Morgan Meads, BS c, Donald P. Pizzo, PhD c, Jessica Diaz-Vigil, BS c, Francesca Soncin, PhD c, d, Kathleen M. Fisch, PhD a, Gladys A. Ramos, MD a, Marni B. Jacobs, PhD a, Mana M. Parast, MD PhD c, d,
a Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Diego, La Jolla, CA 
b University of California San Diego School of Medicine, La Jolla, CA 
c Department of Pathology, University of California San Diego, La Jolla, CA 
d Sanford Consortium for Regenerative Medicine, La Jolla, CA 

Corresponding author: Mana M. Parast, MD, PhD.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Thursday 25 April 2024

Abstract

Background

SARS-CoV-2 infection during pregnancy is associated with an increased risk for stillbirth, preeclampsia, and preterm birth. However, this does not seem to be caused by intrauterine fetal infection because vertical transmission is rarely reported. There is a paucity of data regarding the associated placental SARS-CoV-2 histopathology and their relationship with the timing and severity of infection.

Objective

This study aimed to determine if maternal SARS-CoV-2 infection was associated with specific patterns of placental injury and if these findings differed by gestational age at time of infection or disease severity.

Study Design

A retrospective cohort study was performed at the University of California San Diego between March 2020 and February 2021. Placentas from pregnancies with a positive SARS-CoV-2 test were matched with 2 sets of controls; 1 set was time-matched by delivery date and sent to pathology for routine clinical indications, and the other was chosen from a cohort of placentas previously collected for research purposes without clinical indications for pathologic examination before the SARS-CoV-2 outbreak. Placental pathologic lesions were defined based on standard criteria and included maternal and fetal vascular malperfusion and acute and chronic inflammatory lesions. A bivariate analysis was performed using the independent Student t test and Pearson chi-square test. A logistic regression was used to control for relevant covariates. Regions of SARS-CoV-2–associated villitis were further investigated using protein-based digital spatial profiling assays on the GeoMx platform, validated by immunohistochemistry, and compared with cases of infectious villitis and villitis of unknown etiology. Differential expression analysis was performed to identify protein expression differences between these groups of villitis.

Results

We included 272 SARS-CoV-2 positive cases, 272 time-matched controls, and 272 historic controls. The mean age of SARS-CoV-2 affected subjects was 30.1±5.5 years and the majority were Hispanic (53.7%) and parous (65.7%). SARS-CoV-2 placentas demonstrated a higher frequency of the 4 major patterns of placental injury (all P<.001) than the historic controls. SARS-CoV-2 placentas also showed a higher frequency of chronic villitis and severe chronic villitis (P=.03 for both) than the time-matched controls, which remained significant after controlling for gestational age at delivery (adjusted odds ratio, 1.52; 95% confidence interval, 1.01–2.28; adjusted odds ratio, 2.12; 95% confidence interval, 1.16–3.88, respectively). Digital spatial profiling revealed that programmed death-ligand 1 was increased in villitis-positive regions of the SARS-CoV-2 (logFC, 0.47; adjusted P value =.002) and villitis of unknown etiology (logFC, 0.58; adjusted P value =.003) cases, but it was conversely decreased in villitis-positive regions of the infectious villitis group (log FC, −1.40; adjusted P value <.001).

Conclusion

Chronic villitis seems to be the most specific histopathologic finding associated with SARS-CoV-2 maternal infection. Chronic villitis involves damage to the vasculosyncytial membrane of the chorionic villi, which are involved in gas and nutrient exchange, suggesting potential mechanisms of placental (and perhaps neonatal) injury, even in the absence of vertical transmission. Surprisingly, changes in protein expression in SARS-CoV-2–associated villitis seem to be more similar to villitis of unknown etiology than to infectious villitis.

Le texte complet de cet article est disponible en PDF.

Video


(145.32 Mo)

Le texte complet de cet article est disponible en PDF.

Key words : chronic villitis, COVID, digital spatial profiling, fetal vascular malperfusion, infectious villitis, maternal vascular malperfusion, PD-L1, placenta, SARS-CoV-2, villitis of unknown etiology


Plan


 The authors report no conflict of interest.
 This work was supported by the Department of Pathology, University of California (UC) San Diego funds to M.M.P. and a UC San Diego Academic Senate grant, University of California San Diego under grant number RG104387 to F.S. This research was partially supported by the Altman Clinical & Translational Research Institute (ACTRI) at the University of California, San Diego. The ACTRI is funded by awards issued by the National Center for Advancing Translational Sciences, a division of the National Institutes of Health under grant number UL1TR001442.
 The findings of this study was presented at the 42nd annual pregnancy meeting of the Society for Maternal-Fetal Medicine, Orlando, FL, January 31–February 5, 2022.
 Cite this article as: Gabby LC, Jones CK, McIntyre BB, et al. Chronic villitis as a distinctive feature of placental injury in maternal SARS-CoV-2 infection. Am J Obstet Gynecol 2024;XX:x.ex–x.ex.


© 2024  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.